Breast cancer is the second most common malignancy diagnosed in women, supporting the
need for identification of novel prognostic and diagnostic biomarkers. Recently, microRNAs …

Breast cancer (BC) is the most common malignancy in women. Due to BC heterogeneity,
complexity, and metastasis, many BC patients do not successfully respond to therapies. The …

The expression of microRNAs (miRNAs) in a tissue-and development-specific manner has
indicated that they play an essential role in the maintenance of biological homeostasis. In …

Effective management of breast cancer depends on early diagnosis and proper monitoring
of patients' response to therapy. However, these goals are difficult to achieve because of the …

Abstract microRNAs (miRNAs) are a family of small noncoding RNAs that play a pivotal role
in the regulation of main biological and physiological processes, including cell cycle …

Breast cancer (BC) is the most frequent type of non skin cancer among women and a major
leading cause of cancer-related deaths in Western countries. It is substantial to discover …

Breast cancer is the second most common cause of deaths reported in women worldwide,
and therefore there is a need to identify breast cancer patients at an early stage as timely …

BACKGROUND Successful treatment of breast cancer is enhanced by early detection and, if
possible, subsequent patient-tailored therapy. Toward this goal, it is essential to identify and …

MicroRNAs (miRNAs) are small non-coding RNAs generated by a two-step complex process
and are post transcriptional negative regulators of their target mRNAs. Dysregulation of …

MicroRNAs (miRNAs) are an emerging class of gene expression modulators with relevant
roles in several biological processes, including cell differentiation, development, apoptosis …